Advances in RAB Research
Vol 1 No 1 (2018): Advances in Regulatory Autoantibody Research

Research Article, ID Advances in RAB Research, Vol 1, No 1, 2018 • Article ID: 1809019 • DOI: 10.18416/RAB.2018.18090019

Anti-GPCR antibodies in atherosclerosis

Main Article Content

Zouhair Aherrahrou , Laurence Johanson , Jeanette Erdmann , Gabriela Riemekasten 

Abstract

Cardiovascular diseases, including coronary artery disease (CAD), are considered as killer number one worldwide. The pathology of CAD is caused by atherosclerosis, an inflammatory and immunological disorder. CXCL12 has been reported to be associated with CAD by genome-wide association studies (GWAS) and thus the CXCL12 / CXCR4 axis is determinant in atherosclerosis. CXCR4 belongs to the G proteins-coupled receptors (GPCR), which modulate different cellular functions. Although GPCRs are well established to function in immunity and inflammation, a little is known about their exact role in atherosclerosis. Recent studies pinpointed their therapeutic potential for atherosclerosis and CAD, however strong pre-clinical experimental evidence is still missing to understand whether targeting each of those molecules is protective or detrimental for atherosclerosis.
Here we will provide a short update on the so far published data with regard to the potential implication of both receptors CXCR3 and 4 as well their ligands CXCL9-12 in the context of atherosclerosis. Recently a high anti-CXCR3/4 antibodies in patients with systemic sclerosis (SSc) along with other GPCRs was reported. An attempt to treat atherogenic mice with IgGs from systemic sclerosis (SSc) patients and healthy controls (HC) is in progress. Some of the so far generated preliminary results will be presented and discussed. This update will help us to further extend our better understanding on targeting GPCRs in the context of atherosclerosis.

Article Details

How to Cite

Aherrahrou, Z., Johanson, L., Erdmann, J., & Riemekasten, G. (2018). Anti-GPCR antibodies in atherosclerosis. Advances in RAB Research, 1(1), Advances in RAB Research, Vol 1, No 1, 2018 -. Retrieved from https://journals.infinite-science.de/index.php/rab/article/view/32

Most read articles by the same author(s)
{"cc_re__cc_re__cc_by_4_0": ["\"/>\n<meta name=\"DC.Identifier\" content=\"32\"/>\n<meta name=\"DC.Identifier.pageNumber\" content=\"Advances in RAB Research, Vol 1, No 1, 2018 \u2022 Article ID: 1809019 \u2022 DOI: 10.18416/RAB.2018.18090019\"/>\n<meta name=\"DC.Identifier.URI\" content=\"https://journals.infinite-science.de/index.php/rab/article/view/32\"/>\n<meta name=\"DC.Language\" scheme=\"ISO639-1\" content=\"en\"/>\n<meta name=\"DC.Rights\" content=\"Copyright (c) 2018 Zouhair Aherrahrou, Laurence Johanson, Jeanette Erdmann, Gabriela Riemekasten\"/>\n<meta name=\"DC.Rights\" content=\"https://creativecommons.org/licenses/by/4.0\"/>\n<meta name=\"DC.Source\" content=\"Advances in RAB Research\"/>\n<meta name=\"DC.Source.ISSN\" content=\"2626-4803\"/>\n<meta name=\"DC.Source.Issue\" content=\"1\"/>\n<meta name=\"DC.Source.Volume\" content=\"1\"/>\n<meta name=\"DC.Source.URI\" content=\"https://journals.infinite-science.de/index.php/rab\"/>\n<meta name=\"DC.Subject\" xml:lang=\"en\" content=\"atherosclerosis\"/>\n<meta name=\"DC.Title\" content=\"Anti-GPCR antibodies in atherosclerosis\"/>\n<meta name=\"DC.Type\" content=\"Text.Serial.Journal\"/>\n<meta name=\"DC.Type", "                               Zouhair Aherrahrou&nbsp;,                                             Laurence Johanson&nbsp;,                                             Jeanette Erdmann&nbsp;,                                             Gabriela Riemekasten&nbsp;                     \n                </p>\n            </div> \n                                        <div class=\"additional_information\">\n                                                                                                <a rel=\"license\" href=\"https://creativecommons.org/licenses/by/4.0/\"><img alt=\"Creative Commons License\" src=\"//i.creativecommons.org/l/by/4.0/88x31.png\" /></a><p>This work is licensed under a <a rel=\"license\" href=\"https://creativecommons.org/licenses/by/4.0/\">Creative Commons Attribution 4.0 International License</a>.</p>\n                                                    \n                    </div>\n\n                            <div class=\"article-summary\" id=\"summary\">\n                <h3>Abstract</h3>\n                <div class=\"article-abstract\">\n          ", "                                             Gabriela Riemekasten&nbsp;                     \n                </p>\n            </div> \n                                        <div class=\"additional_information\">\n                                                                                                <a rel=\"license\" href=\"https://creativecommons.org/licenses/by/4.0/\"><img alt=\"Creative Commons License\" src=\"//i.creativecommons.org/l/by/4.0/88x31.png\" /></a><p>This work is licensed under a <a rel=\"license\" href=\"https://creativecommons.org/licenses/by/4.0/\">Creative Commons Attribution 4.0 International License</a>.</p>\n                                                    \n                    </div>\n\n                            <div class=\"article-summary\" id=\"summary\">\n                <h3>Abstract</h3>\n                <div class=\"article-abstract\">\n                    <p>Cardiovascular diseases, including coronary artery disease (CAD), are considered as killer number one worldwide. The pathology of CAD is caused by atherosclerosis, an inflammatory "], "copyright__copyright__copyright": ["s will be presented and discussed. This update will help us to further extend our better understanding on targeting GPCRs in the context of atherosclerosis.\n\nArticle Details\n\nHow to Cite\n\nAherrahrou, Z., Johanson, L., Erdmann, J., & Riemekasten, G. (2018). Anti-GPCR antibodies in atherosclerosis. Advances in RAB Research, 1(1), Advances in RAB Research, Vol 1, No 1, 2018 -. Retrieved from https://journals.infinite-science.de/index.php/rab/article/view/32\n\nMost read articles by the same author(s)"]}